An Outlook on 2026 AI IPOs
A Historic Reopening of the IPO Window After a long period of subpar issuance, the U.S. IPO market is staging a strong comeback in 2026,…
The Investor Standard – Your Investing Edge
Receive curated weekly stock picks, top-performing equities, and actionable investment ideas to maximise your portfolio potential.
Investor Insights, Delivered
Unlock expert insights, stock recommendations, and market analysis – all in one place. Get the latest market news and stock picks instantly.
Further Analysis & Commentary
ASX Stocks in Focus: Five Quality Picks for a Resilient Portfolio
Markets heading into 2026 are being shaped less by single headlines and more by structural forces, persistent inflation pressures, uneven…
An outlook on ETFs. Are ETFs a Viable Investment?
Over the past several decades, exchange‑traded funds (ETFs) have evolved dramatically, moving well beyond their original role as simple, conventional…
Global Markets Consolidate After Fed Pause, S&P Breaks $7000
Global markets traded in a consolidative range overnight as investors digested the Fed's latest policy decision, resilient economic data and…
Investment Analysis: Mesoblast Ltd (ASX: MSB)
Business Summary Mesoblast Limited specializes in developing allogeneic, “off‑the‑shelf” cellular medicines designed to treat severe inflammatory conditions. The company’s late‑stage…
Socials
Monthly Investor Memo
Delivered Monthly - 2026